Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCIENCE stem cell therapy in ischemic non-treatable cardiac disease
2015-002929-19Phase 2Active
- Sponsor
- Department of Cardiology, Rigshospitalet
- Start
- Nov 2015
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronary arteriosclerosis and heart failure (HF) comparing CSCC_ASC active treatment with Placebo (2 arms). Primary endpoint: Change in left ventricle end-systolic volume. Started Nov 2015; status: active.
02
Drugs
CSCC_ASC
03
Conditions
coronary arteriosclerosisheart failure (HF)
Beyond the preview
Go deeper on 2015-002929-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002929-19.